Image Credit: Tectonic Therapeutic Announcement The Tectonic Therapeutic Inc. has showcased its successful positive topline results from the phase 1b part B acute hemodynamic clinical trial of TX45. It’s a long reactive Fc-relaxin fusion protein in patients going through group 2 PH-H...
Announcement Savara Inc., a US-based clinical-level biopharmaceutical company focusing on rare respiratory diseases, has signed a $75 million royalty funding agreement with RTW Investments, LP, managing the funding process, which is entitled to FDA clearance of MOLBREEZI. The royalty financing wil...
Image Credit: AtriCure Announcement AtriCure, Inc., a well-known innovator in surgical therapies and treatments for atrial fibrillation (Afib), post-operative pain management, and left atrial appendage (LAA) management, proudly announced its first patient enrollment and treatment in the Box lesi...
Image Credit: Harbour Biomed Announcement Harbour BioMed, a leading biopharmaceutical company aiming at the establishment and discovery of novel antibody therapeutics in oncology and immunology, has introduced the first and best-in-class fully fledged human generative AI HCAb (Heavy chain-only a...
Image Credit: Genprex Announcement Genprex, Inc., a leading clinical-level gene therapy company aiming to develop and advance life-changing therapies for diabetes and cancer patients, has signed a definitive agreement for the sale and purchase of 377.780 shares of common stock at a buyout ...
Image Credit: Ferring Pharmaceuticals Announcement Ferring Pharmaceuticals confirmed that three abstracts focusing on ADSTILADRIN will be showcased at the 101st Annual Meeting of the Western Section of the American Urological Association (AUA) in Napa, to be held from November 2 to 6, 2025...
Image Credit: Wavelifesciences Announcement Wave Life Sciences Ltd, a leading clinical-level biotechnology company dedicated towards unveiling the broader spectrum of capability of RNA medicines to convert into a human health, have confirmed its positive activin E target engagement data. T...
Image Credit: Medtronic Announcement Medtronic, a popular medical technology leader, will inaugurate its first-ever digital healthcare innovation hub in Beijing, China. The hub is engineered to deliver an excellent ecosystem for testing and establishing the AI-fueled, data-oriented healthc...
Image Credit: Faeth Therapeutics Announcement Faeth Therapeutics, a leading clinical-level biotechnology company focusing on the advancement of specific therapies focusing on tumour metabolism, has declared one more advancement of its popular PIKTOR regimen in endometrial cancer. Additionally, t...
Announcement The bridgeBio Pharma’s in-progress investigational oral small molecule BBP-418, an under-development study to cure a particular form of limb-girdle muscular dystrophy, has entered a late-stage trial. Following this, the new drug application is planned to proceed by the first half...
